More generally concerning RAD51B involvement in cancer, previous studies have identified chromosomal rearrangements disrupting RAD51B in benign tumours, particularly uterine leiomyomas [31,32]. This evidence concerns the gene RAD51B and uterine corpus leiomyoma.